Prevention Through Intervention: Telehealth Solution to Deter 911 Calls Due to Hypoglycemia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03665870|
Recruitment Status : Recruiting
First Posted : September 11, 2018
Last Update Posted : October 11, 2018
|Condition or disease||Intervention/treatment||Phase|
|Diabetes Mellitus Hypoglycemia Unawareness Hypoglycemia Hypoglycemia Acute||Behavioral: Hypoglycemia Education||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Single arm pre-post study.|
|Masking:||None (Open Label)|
|Official Title:||Prevention Through Intervention: Telehealth Solution to Deter 911 Calls Due to Hypoglycemia|
|Actual Study Start Date :||October 1, 2018|
|Estimated Primary Completion Date :||May 24, 2019|
|Estimated Study Completion Date :||October 24, 2019|
Experimental: Intervention Arm
Hypoglycemia Education: Participants will receive educational support to prevent repeat episodes of hypoglycemia.
Behavioral: Hypoglycemia Education
Two in-person visits to the home of the participant and 4 phone calls will be conducted to provided education on prevention of hypoglycemia.
- Fear of Hypoglycemia [ Time Frame: Through study completion, an average of 8 weeks ]One of the most important impact of hypoglycemia, is non-compliance to diabetes treatment due to the fear of hypoglycemia. This would be measured using the "Hypoglycemia Scale: FH-15" scale.
- Self Efficacy [ Time Frame: Pre and Post (after 8 weeks)Through study completion, an average of 8 weeks ]Measured using the "Perceived Diabetes Self-Management Scale".
- Knowledge of Diabetes [ Time Frame: Through study completion, an average of 8 weeks ]Measured using the "The Knowledge in Low Literacy in Diabetes Knowledge Assessment Scale"
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03665870
|Contact: Mohanraj Thirumalai, PhDfirstname.lastname@example.org|
|United States, Alabama|
|Birmingham Fire and Rescue Service||Recruiting|
|Birmingham, Alabama, United States, 35209|
|Contact: Ben Thompson 205-569-7883 email@example.com|
|Principal Investigator:||Mohanraj Thirumalai, PhD||University of Alabama at Birmingham|